A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

This multicenter study investigates the association between hydroxychloroquine (HCQ) dosage and COVID-19 mortality among ...

Single doses of 150 milligrams (mg), 300 mg, and 450 mg provided 58%, 61%, and 76% protection from symptomatic flu, ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

A new study from UCLA Health suggests COVID-19 vaccines may protect patients from severe kidney damage. The study found hospitalized COVID-19 patients were less likely to have severe kidney damage ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

Because COVID-19 is caused by a virus, antibiotics cannot be used to treat it. However, Pulia says physicians may feel they are erring on the safe side by assuming the patient could also have ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent higher for ...

New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem ...

Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine. This program can improve health-related ...

SARS-CoV-2 infection is linked to significant declines in sperm quality, including reduced sperm count, motility, and increased DNA fragmentation, as shown in both cross-sectional and longitudinal ...